ARCHIVES

NIEHS Director Olden Outlines Strategy For Carcinogenicity Testing

This article is from The Cancer Letter archive.

Vol. 18 No. 35 | September 11, 1992

Download PDF Visit The Full Archive

Related Articles

In Brief: FDA Advisors Ask Cetus To Refine IL-2 Application; NIH Reauthorization Introduced

August 3, 1990

Anti-NCI Forces Fail to Raid $70 Million from Cancer Program

September 26, 1975

In Brief: San Antonia Cancer Institute Designated Comprehensive; Yeast DNA Described

May 3, 1996

UCSD Cancer Center Breaks Ground for New Building

November 15, 2002

FDA approves Irinotecan, Days After ODAC Meeting

June 21, 1996

NCI Clinical Trials Enrollment Drops to 17,500

February 21, 2014